mortality/aging
| N |
• homozygous mutant pups obtained from heterozygous crossings are slightly underrepresented at birth (15% vs expected 25%); however, no decrease in the number of pups is observed in homozygous crossings
|
hearing/vestibular/ear
|
• by P35, homozygotes display complete IHC degeneration
• however, no morphological IHC changes are noted up to P14
|
|
• at P14, homozygotes display an early and severe OHC degeneration starting on the apical side
(J:63515)
• OHC degeneration is complete by P35
(J:63515)
• at P15, severe loss of OHCs occurs exclusively in low frequency (LF; apical/medial) cochlear turns, whereas high frequency (HF; midbasal/basal) OHCs remain histologically intact
(J:117764)
|
|
• at P9, mutant cochlear IHCs display a >90% reduction in voltage-gated L-type Ca2+ currents, leading to a nearly complete loss of Ca2+ influx which normally couples sound-evoked depolarization to neurotransmitter release at the IHC synapse
(J:63515)
• at P22, mutant IHCs show complete absence of expression of the BK channel in all cochlear turns (both LF and HF)
(J:117764)
|
|
• prior to OHC degeneration, homozygotes show complete absence of expression of the Ca2+-activated large conductance K+ (BK) channel in LF apical/medial turns
• in contrast, OHCs in the remaining HF (midbasal/basal) turns display regular expression of the BK channel at P22
• despite deafness, young (1-mo-old) homozygotes display mechanically intact OHCs in HF (midbasal/basal) cochlear turns, as shown by functional DPOAEs
|
|
• as early as P14, all homozygotes exhibit increased auditory thresholds (>120 db SPL) relative to age-matched wild-type mice (50-60 db SPL)
(J:63515)
• at 5-8 weeks, mutant auditory thresholds are >120 dB SPL relative to wild-type thresholds (30-40 db SPL)
(J:63515)
|
|
• at P30, growth functions of DPOAEs are reduced in amplitude but significantly above noise level beyond 40 dB SPL f1, indicating active cochlear mechanics at moderate to high stimulus frequencies despite deafness
• however, at >2 months, growth functions are significantly reduced and no longer differ from the noise floor level, indicating a decline in cochlear mechanics
|
|
• all homozygotes are congenitally deaf, as shown by complete absence of typical click-evoked auditory brainstem response (ABR) waveforms above 30 dB SPL at P14
(J:63515)
|
cardiovascular system
|
• hearts are susceptible to atrial tachyarrhythmias
• injection of the A1 adenosine receptor (A1R)-selective agonist 2-chloro, N6-cyclopentyl adenosine (CCPA) during A1R-induced bradycardia strongly slows heart rate similarly to wild-type mice and induces deep SAN bradycardia and very low heart rate
|
|
• unlike wild-type mice, homozygotes exhibit severe arrhythmia, as shown by a high standard deviation of R-R intervals at rest
• arrhythmia is reduced during enhanced spontaneous physical activity, and abolished after block of cardiac muscarinic receptors by atropine
|
|
• mice show high variability of heart rate variability (supraventricular arrhythmia)
• the IKACh (Kcnj5) peptide blocker tertiapin-Q improves heart rate
|
|
• unlike wild-type mice, homozygotes exhibit severe bradycardia, as shown by an increased mean R-R interval at rest
• bradycardia is reduced during enhanced spontaneous physical activity, and abolished after block of cardiac muscarinic receptors by atropine
• however, bradycardia persists after methoxamine treatment, as R-R intervals are increased in both mutant and wild-type mice to similar extents
|
|
• unlike wild-type mice, homozygotes display an increased mean R-R interval and a high standard deviation of R-R intervals at rest
• however, QRS complexes are triggered by normal P waves and are of normal duration
|
|
• mice exhibit sinoatrial node (SAN) bradycardia
|
|
• mice exhibit atrial tachycardia after intracardiac atrial stimulation
|
|
• mice exhibit atrial fibrillation after intracardiac atrial stimulation
|
|
• ECG recordings at rest indicate altered sinoatrial node pacemaker activity (bradycardia and arrhythmia)
(J:63515)
• sinoatrial node dysfunction is confirmed in completely denervated, spontaneously beating isolated atria, where mutants display a significant bradycardia and/or arrhythmia relative to wild-type mice
(J:63515)
• however, myocardial architecture, myocyte shape and size, and sinoatrial node architecture is normal, and normal pacemaker activity can be reestablished after atropine treatment
(J:63515)
• sinoatrial node pauses
(J:230439)
• treatment with atropine and propranolol abolishes SAN pauses
(J:230439)
• treatment with atropine to block muscarinic receptors reduces the frequency of SAN pauses
(J:230439)
• the IKACh (Kcnj5) peptide blocker tertiapin-Q rescues SAN dysfunction
(J:230439)
|
heart block
(
J:230439
)
|
• severe atrioventricular dysfunction typical of congenital heart block
|
|
• unlike wild-type mice, 7 of 11 homozygotes exhibit episodes of second-degree AV block
(J:63515)
• frequent episodes of atrioventricular (AV) block
(J:230439)
• treatment with atropine and propranolol abolishes AV blocks
(J:230439)
• the IKACh (Kcnj5) peptide blocker tertiapin-Q rescues AV block
(J:230439)
|
|
• homozygotes exhibit a prolonged PR interval relative to wild-type mice (543 ms vs 432 ms, respectively)
(J:63515)
• prolonged atrioventricular conduction time (PR interval)
(J:230439)
• the PR interval of hearts is more than doubled by acetycholine perfusion
(J:230439)
|
|
• acetylcholine decreases pacemaker activity of myocytes by increasing the incidence of delayed after-depolarizations, leaving unaffected the slope of the diastolic depolarization rather than by reducing the slop of the diastolic depolarization and by increasing the frequency of delayed after-depolarizations as in wild-type mice
• slower frequency of spontaneous intracellular calcium transients in sinoatrial node myocytes
|
behavior/neurological
|
• all homozygotes fail to exhibit a Preyer reflex in response to hand claps
|
nervous system
|
• by P35, homozygotes display complete IHC degeneration
• however, no morphological IHC changes are noted up to P14
|
|
• at P14, homozygotes display an early and severe OHC degeneration starting on the apical side
(J:63515)
• OHC degeneration is complete by P35
(J:63515)
• at P15, severe loss of OHCs occurs exclusively in low frequency (LF; apical/medial) cochlear turns, whereas high frequency (HF; midbasal/basal) OHCs remain histologically intact
(J:117764)
|
|
• at P9, mutant cochlear IHCs display a >90% reduction in voltage-gated L-type Ca2+ currents, leading to a nearly complete loss of Ca2+ influx which normally couples sound-evoked depolarization to neurotransmitter release at the IHC synapse
(J:63515)
• at P22, mutant IHCs show complete absence of expression of the BK channel in all cochlear turns (both LF and HF)
(J:117764)
|
|
• prior to OHC degeneration, homozygotes show complete absence of expression of the Ca2+-activated large conductance K+ (BK) channel in LF apical/medial turns
• in contrast, OHCs in the remaining HF (midbasal/basal) turns display regular expression of the BK channel at P22
• despite deafness, young (1-mo-old) homozygotes display mechanically intact OHCs in HF (midbasal/basal) cochlear turns, as shown by functional DPOAEs
|
|
• by P35, homozygotes show complete degeneration of the afferent nerve fibers and ganglion cells
• however, no morphological ganglion cell changes are noted up to P14
|
|
• atrial myocytes exhibit shortened action potential duration
|
homeostasis/metabolism
| N |
• homozygotes display no significant differences in plasma norepinephrine or thyroid hormone (free T3 or T4) concentrations relative to wild-type mice
• also, homozygotes show no differences in serum glucose and insulin levels during fasting or after glucose challenge relative to wild-type mice
|
|
• at P9, mutant cochlear IHCs display a >90% reduction in voltage-gated L-type Ca2+ currents, leading to a nearly complete loss of Ca2+ influx which normally couples sound-evoked depolarization to neurotransmitter release at the IHC synapse
• in contrast, no gross abnormalities are noted in vestibular function or structure up to P35
|


Analysis Tools